*<p>Costs include direct costs and indirect costs. Direct costs are costs that are directly related to the provision of care to the patient and include Nursing (incl. Operating Room, ICU), Diagnostic Imaging, Pharmacy and Labs. Indirect costs are overhead expense relating to the running of hospitals and include administration, finance, human resources, plant operations etc.</p>±<p>Lognormal(mean, median).</p>†<p>Chair time: Cancer Care Ontario Drug Formulary <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0038557#pone.0038557-CancerCareOntarioDrug1" target="_blank">[15]</a>; overhead costs: 2002 costs <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0038557#pone.0038557-Mittmann2" target="_blank">[...
To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line tr...
BackgroundResource and cost issues are a growing concern in health care. Thus, it is important to ha...
To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line tr...
BACKGROUND: Cancer is a major public health issue and represents a significant economic burden to he...
Introduction Case costing is the only source of integrated financial, clinical, and utilization data...
Background and Objective: The increasing cost of chemotherapy is placing greater pressures on limite...
Background and Objective: The increasing cost of chemotherapy is placing greater pressures on limite...
We conducted an analysis of indirect costs alongside the LY.12 randomized trial in patients with rel...
Aim: To determine the monthly treatment costs for each element of cancer care in patients receiving ...
Background: In flat-rate reimbursement systems, the hospital's own costs should not exceed its reven...
Background: The first year after cancer diagnosis is a period of intensive treatment and high cost. ...
Aim: To determine the monthly treatment costs for each element of cancer care in patients receiving ...
Purpose: To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in firs...
BackgroundCosting studies are useful to measure the economic burden of cancer. Comparing costs betwe...
Background/Aim: This cross-sectional study estimated direct cancer-related health care, productivity...
To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line tr...
BackgroundResource and cost issues are a growing concern in health care. Thus, it is important to ha...
To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line tr...
BACKGROUND: Cancer is a major public health issue and represents a significant economic burden to he...
Introduction Case costing is the only source of integrated financial, clinical, and utilization data...
Background and Objective: The increasing cost of chemotherapy is placing greater pressures on limite...
Background and Objective: The increasing cost of chemotherapy is placing greater pressures on limite...
We conducted an analysis of indirect costs alongside the LY.12 randomized trial in patients with rel...
Aim: To determine the monthly treatment costs for each element of cancer care in patients receiving ...
Background: In flat-rate reimbursement systems, the hospital's own costs should not exceed its reven...
Background: The first year after cancer diagnosis is a period of intensive treatment and high cost. ...
Aim: To determine the monthly treatment costs for each element of cancer care in patients receiving ...
Purpose: To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in firs...
BackgroundCosting studies are useful to measure the economic burden of cancer. Comparing costs betwe...
Background/Aim: This cross-sectional study estimated direct cancer-related health care, productivity...
To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line tr...
BackgroundResource and cost issues are a growing concern in health care. Thus, it is important to ha...
To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line tr...